Genzyme

NEXVIAZYME

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genzyme

Nexviazyme HCPCS:

J0219

HCPCS Code Descriptor:

Injection, avalglucosidase alfa-ngpt, 4 mg

Category:

J Code

Nexviazyme NDCs:

58468-0426-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Nexviazyme CPT Codes:

-96365 - Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour

-96366 - Each additional hour (list separately in addition to code for primary procedure; report 96366 for infusion intervals of greater than 30 minutes beyond 1-hour increments)*

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Nexviazyme:

NEXVIAZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0219 is aligned to the drug NEXVIAZYME.

ACCESS PRICING AND MORE BY REGISTERING

J0219 Added Date:

April 1, 2022

J0219 Effective Date:

April 1, 2022

J0219 Termination Date:

HCPCS Active

View a Nexviazyme billing and coding guide at the link below:
Nexviazyme patient assistance information can be found through CareconnectPSS at the URL: https://www.careconnectpss.com/get-support
NEXVIAZYME prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for NEXVIAZYME. Please check back in a few weeks.